The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms

References

• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–112.
   PubMed Web of Science ®Google Scholar
• Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex. 1991;1(1):103–116.
   PubMed Web of Science ®Google Scholar
• Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology. 1992;42(3):631–631.
   PubMed Web of Science ®Google Scholar
• Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389–404.
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259.
   PubMed Web of Science ®Google Scholar
• Thal DR, Rüb U, Orantes M, et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791–1800.
   PubMed Web of Science ®Google Scholar
• Cho H, Choi JY, Hwang MS, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol. 2016;80(2):247–258.
   PubMed Web of Science ®Google Scholar
• Malpas CB, Saling MM, Velakoulis D, Desmond P, O’Brien TJ. Tau and amyloid-β cerebrospinal fluid biomarkers have differential relationships with cognition in mild cognitive impairment. J Alzheimer’s Dis. 2015;47(4):965–975.
   PubMed Web of Science ®Google Scholar
• Nelson PT, Alafuzoff I, Bigio EH, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71(5):362–381.
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Wilson RS, et al. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004;61(3):378–384.
   PubMedGoogle Scholar
• Murray ME, Lowe VJ, Graff-Radford NR, et al. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum. Brain. 2015;138(5):1370–1381.
   PubMed Web of Science ®Google Scholar
• Bejanin A, Schonhaut DR, La Joie R, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain. 2017;140(12):3286–3300.
   PubMed Web of Science ®Google Scholar
• Hedden T, Oh H, Younger AP, et al. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology. 2013;80(14):1341–1348.
   PubMed Web of Science ®Google Scholar
• Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology. 1991;41(4):479–479.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis S, Forstmann BU, Wagenmakers E-J. Erroneous analyses of interactions in neuroscience: a problem of significance. Nat Neurosci. 2011;14(9):1105–1107.
   PubMed Web of Science ®Google Scholar
• Besser LM, Kukull WA, Teylan MA, et al. The revised National Alzheimer’s Coordinating Center’s Neuropathology Form—available data and new analyses. J Neuropathol Exp Neurol. 2018;77(8):717–726.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol. 2012;123(1):1–11.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
   PubMed Web of Science ®Google Scholar
• Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(S1):173–176.
   PubMedGoogle Scholar
• Pfeffer R, Kurosaki T, Harrah C, Jr, et al. Measurement of functional activities in older adults in the community. Journal of Gerontology. 1982;37(3):323–329.
   PubMedGoogle Scholar
• Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–239.
   PubMed Web of Science ®Google Scholar
• Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing, 2019.
   Google Scholar
• Bürkner P-C. brms: an R package for Bayesian multilevel models using Stan. J Stat Soft. 2017;80(1):1–28.
   Web of Science ®Google Scholar
• Bürkner P-C. Advanced Bayesian multilevel modeling with the R package brms. R J. 2018;10(1):395–411.
   Google Scholar
• Carpenter B, Gelman A, Hoffman MD, et al. Stan: a probabilistic programming language. J Stat Soft. 2017;76(1):1–43.
   PubMed Web of Science ®Google Scholar
• Gelman A, Stern HS, Carlin JB, et al. Bayesian data analysis. Boca Raton (FL): Chapman and Hall/CRC, 2013.
   Google Scholar
• Gelman A, Goodrich B, Gabry J, et al. R-squared for Bayesian regression models. Am Statist. 2019;73(3):307–309.
   Web of Science ®Google Scholar
• McElreath R. 2018. Statistical rethinking: a Bayesian course with examples in R and Stan. Boca Raton (FL): Chapman and Hall/CRC.
   Google Scholar
• Jack CR, Wiste HJ, Schwarz CG, et al. Longitudinal tau PET in ageing and Alzheimer’s disease. Brain. 2018;141(5):1517–1528.
   PubMed Web of Science ®Google Scholar
• Johnson KA, Schultz A, Betensky RA, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79(1):110–119.
   PubMed Web of Science ®Google Scholar
• Pontecorvo MJ, Devous MD, Sr, Navitsky M, et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain. 2017;140(3):748–763.
   PubMed Web of Science ®Google Scholar
• Malpas CB, Saling MM, Velakoulis D, et al. Differential functional connectivity correlates of cerebrospinal fluid biomarkers in dementia of the Alzheimer’s type. Neurodegener Dis. 2016;16(3-4):147–151.
   PubMed Web of Science ®Google Scholar
• Malpas CB, Saling MM, Velakoulis D, et al. cerebrospinal fluid biomarkers are differentially related to structural and functional changes in dementia of the Alzheimer’s type. J. Alzheimer’s Dis. 2018;62(1):417–427.
   PubMed Web of Science ®Google Scholar
• Tolar M, Abushakra S, Sabbagh M. 2019. The path forward in Alzheimer’s disease therapeutics: reevaluating the amyloid cascade hypothesis. Alzheimer’s Dement. in press.
   Web of Science ®Google Scholar
• Ceyzériat K, Zilli T, Millet P, et al. Learning from the past: a review of clinical trials targeting amyloid, tau and neuroinflammation in Alzheimer’s disease. Curr Alzheimer Res. 2020;17.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol. 2011;121(2):171–181.
   PubMed Web of Science ®Google Scholar
• Braak H, Thal DR, Ghebremedhin E, et al. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960–969.
   PubMed Web of Science ®Google Scholar
• Villemagne VL, Doré V, Bourgeat P, et al. Aβ-amyloid and tau imaging in dementia. Semin Nucl Med. 2017;47(1):75–88.
   PubMed Web of Science ®Google Scholar
• Palacios S, Henderson V, Siseles N, et al. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric. 2010;13(5):419–428.
   PubMed Web of Science ®Google Scholar
• Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014;142:90–98.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Aisen P, Beckett LA, et al. Alzheimer’s disease neuroimaging initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201–209.
   PubMed Web of Science ®Google Scholar
• Ellis KA, Bush AI, Darby D, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int Psychogeriatr. 2009;21(4):672–687.
   PubMed Web of Science ®Google Scholar
• Villemagne VL, Fodero-Tavoletti MT, Masters CL, et al. Tau imaging: early progress and future directions. Lancet Neurol. 2015;14(1):114–124.
   PubMed Web of Science ®Google Scholar